Patent Yard Sign in
Expired Canadian patentCanada

Cephem and cepham compounds and processes for preparation thereof

CA 1182460 A · Owner: Fujisawa Pharmaceutical Co. Ltd. · Inventors: Sakane, Kazuo; Goto, Jiro; Teraji, Tsutomu

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Intermediates of the formula (III): (III), wherein R1 is amino or a protected amino and X1 is carbonyl or a group of the formula:, in which R2 is hydrogen acyl, aryl which may be substituted with suitable substituent(s), lower alkyl substituted with suitable substituent(s), lower alkenyl, lower alkynyl cycloalkyl which may, be substituted with suitable substituent(s) cyclo(lower)-alkenyl, or S or O containing 5-membered heterocyclic group substituted with oxo group(s), or a salt thereof are useful in the preparation of 7-substituted-3-cephem and cepham-4-carboxylic acids which exhibit antimicrobial activities against a wide variety of pathogenic microorganisms including Gram negative and …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted February 12, 1985. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended February 12, 2002.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 28, 1979
GrantedFebruary 12, 1985
Term endedFebruary 12, 2002
Patent numberCA 1182460 A
Classification (IPC)C07D285/08 +1 more

Timeline

Timeline From CIPO dates

19801983198619891992199519982001Application filedDec 28, 1979Patent grantedFeb 12, 1985Term endedFeb 12, 2002

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.